| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
5
5
1
2
1
|
|
Zacks Investment Research
---
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
D-
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 4.23 | 4.11 | 0.13 |
| Stocks | 0.48 | 0.0 | 0.48 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.02 | 0.0 | 0.02 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 99.38 | 0.0 | 99.38 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Novartis AG | NVSEF | 17.5 | 3.09 |
| Sanofi | SAN | --- | 2.97 |
| Mini Msci Eafe Jun13 | --- | --- | 2.88 |
| Vodafone Group PLC | VODPF | 21.77 | 2.68 |
| Royal Dutch Shell PLC Class A | RYDAF | -0.16 | 2.23 |
| Barclays PLC | BCLYF | 3.02 | 1.87 |
| Reed Elsevier NV | REN | --- | 1.85 |
| Daimler AG | DDAIF | 5.22 | 1.84 |
| Akzo Nobel NV | AKZOF | 0.87 | 1.61 |
| Jardine Cycle & Carriage Ltd. | C07 | --- | 1.57 |
